Table 1 Clinical characteristics of cystic fibrosis patients.
From: Peroxisome Proliferator-Activated Receptor α (PPARα) down-regulation in cystic fibrosis lymphocytes
Patient | Age (years) | Gender | Genotype | P.a.1 | CRP | FEV1 % pred2 | FVC % pred2 |
|---|---|---|---|---|---|---|---|
1 | 33 | F | dF508/R553x | + | 0,9 | 58 | 91 |
2 | 25 | M | dF508/dF508 | + | 0,5 | 74 | 90 |
3 | 30 | M | dF508/dF508 | + | 0,7 | 42 | 72 |
4 | 34 | M | dF508/? | + | 0,3 | 59 | 80 |
5 | 37 | M | dF508/dF508 | + | 0,6 | 52 | 84 |
6 | 32 | F | dF508/dF508 | + | 2 | 60 | 75 |
7 | 26 | F | dF508/dF508 | + | 1,32 | 86 | 87 |
8 | 28 | M | dF508/? | + | 0,91 | 31 | 48 |
9 | 37 | M | dF508/dF508 | + | < 0,3 | 30 | 43 |
10 | 32 | F | dF508/dF508 | + | < 0,3 | 76 | 92 |
11 | 23 | M | dF508/? | + | < 0,3 | 103 | 99 |
12 | 37 | M | dF508/dF508 | - | < 0,3 | 74 | 101 |
13 | 34 | F | dF508/dF508 | + | 0,94 | 23 | 59 |
14 | 39 | M | dF508/dF508 | - | < 0,3 | 60 | 83 |
15 | 25 | M | dF508/R553x | + | 1,03 | 85,9 | 79,7 |
16 | 22 | F | dF508/N1303 | + | 0,9 | 53,6 | 64,6 |
17 | 43 | M | dF508/dF508 | + | < 0,3 | 98,8 | 95,5 |
18 | 23 | M | dF508/dF508 | + | 0,8 | 85,3 | 84,5 |
19 | 39 | M | dF508/G542x | + | 0,4 | 61 | 79 |
20 | 40 | M | dF508/? | + | 0,4 | 64 | 80 |